NEU 2.59% $13.56 neuren pharmaceuticals limited

qualitative analysis - neu, page-21

  1. 11,705 Posts.
    lightbulb Created with Sketch. 1690
    "a 50% likelyhood of success" for Motiva would actually be amazing, given its potential market.

    But it's nnz2256 which has always excited me, after all its derived from something that already works in humans.

    Motiva and Persis are just two great add-ons, but both offer huge potential.

    cheers
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.